Current Role and Responsibilities
Lizabeth Leveille serves as Vice President, Business Development & Licensing (BD&L) and is the Head of both the Merck Boston Innovation Hub and the European Innovation Hub, as well as the Discovery Transactions Team at Merck & Co. In these capacities, she leads multiple BD&L teams focused primarily on early-stage therapeutics, specifically targeting assets prior to human proof-of-concept. Her leadership covers innovation scouting, collaboration, licensing, and M&A strategies aimed at accessing groundbreaking research and technology from academic, pharmaceutical, and biotechnology sectors.
She is responsible for driving Merck’s early innovation pipeline development through both internal discovery and external partnerships, with a strategic focus on pioneering deals and innovative collaborations worldwide, including significant activities within U.S., European, and Chinese markets.
Professional Experience and Tenure
Ms. Leveille has accumulated over 25 years of industry experience, with more than 20 years dedicated to business development at large pharmaceutical companies. She has been at Merck for over a decade, during which she has stewarded several high-impact transactions. Notable deals under her leadership include:
- Acquisition of Themis Bioscience
- Collaborations with Astex Pharmaceuticals and Taiho Pharmaceuticals
Prior to joining Merck, she spent nine years at Novartis Institutes for BioMedical Research (NIBR) on the business development team, where she engaged in search and evaluation initiatives and led negotiations for licensing, collaboration, and M&A deals. Important transactions included Novartis' acquisition of CoStim Pharmaceuticals and licensing arrangements with companies such as Servier and Peptidream.
Her early career included scientific roles at AVEO Pharmaceuticals, Akceli, Millennium, and Genzyme, providing her with a comprehensive understanding of drug discovery and development from both scientific and commercial perspectives.
Educational Background
- Bachelor of Science in Biotechnology, Worcester Polytechnic Institute
- Master of Science in Biotechnology, Worcester Polytechnic Institute
- Master of Business Administration (MBA), F.W. Olin Graduate School of Business, Babson College
Areas of Strategic Focus
- Leadership in early-stage biotech partnering and dealmaking, emphasizing discovery-stage therapeutic opportunities
- Oversight of innovation hubs fostering collaboration ecosystems in Boston and Europe
- Active engagement in business development to strengthen Merck’s R&D pipeline through licensing, partnerships, and acquisitions
- Commercialization strategies emphasizing novel scientific platforms and technologies across oncology, immunology, and other therapeutic areas
Market and Regional Expertise
Lizabeth has been instrumental in expanding Merck’s footprint in early-stage innovation hubs with broad geographic reach:
- Coordinates the Boston Innovation Hub and the European Innovation Hub, key nodes in the company’s external innovation strategy
- Leads business development activities involving partnerships with Chinese biotech companies, facilitating international collaborations and licensing agreements
Public Engagement and Industry Influence
Ms. Leveille frequently participates in industry-leading forums and conferences, including:
- BIO International Convention (multiple years, including 2023 and upcoming 2025 events)
- Oncology VIP Summit 2025
- Flagship Pioneering events on early-stage dealmaking
Her expertise is regularly solicited for panel discussions and podcasts where she highlights Merck’s approach to leveraging cutting-edge science for business development and licensing, emphasizing the value of collaboration and strategic risk-taking in early drug discovery.
Recognition and Industry Standing
- Recognized within the Massachusetts Biotechnology Council (MassBio) as a board member, underscoring her leadership role in the local and broader biotech ecosystem
- Credited with maintaining Merck's reputation for leading-edge scientific collaborations and pioneering innovative business development models
Relevant Contact and Public Profile Links
- [LinkedIn Profile](https://linkedin.com/in/lizabeth-leveille)
- [MassBio Board Profile](https://www.massbio.org/about/board-of-directors/lizabeth-leveille/)
- [BIO International Speaker Profile](https://www.bio.org/events/bio-international-convention/speakers/1985212)
- [Merck "Meet the Dealmakers" Podcast Transcript](https://www.merck.com/wp-content/uploads/sites/124/2023/06/Merck_Meet_the-Dealmakers_podcast_transcript.pdf)
This comprehensive profile highlights Lizabeth Leveille’s extensive industry experience, her strategic leadership role within Merck’s global innovation hubs, and her influential presence in the pharmaceutical business development arena, especially in early-stage therapeutic partnering and licensing. Her expertise and roles position her as a pivotal figure in Merck’s external innovation and collaboration strategy.
